BioSpace News Archive

CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, today highlighted that Orphazyme A/S (ORPHA.CO)

Primmune Therapeutics today announced the initial closing of a $27.4 million Series A financing to advance the development of novel orally-administered, small molecule toll-like receptor 7 (TLR7) agonists as therapeutic-adjuvants for acute viral diseases and cancer.

Paramit Corporation announced today that as part of its planned strategic expansion into Europe , it has agreed to acquire Austrian-based S.I.E. SOLUTIONS. Paramit, headquartered in Silicon Valley with operations in California and Malaysia , designs and manufactures electronics based medical devices and life science ins

Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handsets and wireless devices, will release financial results for the third quarter ended September 30, 2020 after market close on Tuesday, November 10, 2020.

Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) is providing the following answers to frequently asked questions to its stockholders with regard to Proposal 4, which is being considered at the Company’s Annual Stockholders’ Meeting (the “Annual Meeting”) on October 29, 2020. Only stockholders of record on September 1, 2020, or the record date, are eligible to attend and vote on proposals presented at the Annual Meeting.

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has made available an updated corporate presentation and business summary overview on M-Vest.com . The Company plans to provide regular updates through this website. Please visit www.m-vest.com/insights/spotlight/biolase-inc to ac

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will host a Virtual Analyst Day on Tuesday, November 17, 2020 at 4:00 p.m. Eastern time. The Virtual Analyst Day will be broadcasted via webcast, and include a review of the company’s research and development pipeline and a business update from management, followed by a Q&A session with the sell-side analyst community. Agenda: Date:

Ology Bioservices Inc. (Ology Bio), a biologics contract development and manufacturing organization (CDMO), announced today that the Department of Defense (DOD), through the Joint Science and Technology Office of the Defense Threat Reduction Agency (DTRA), has awarded the company with a contract to manufacture a novel live attenuated tularemia vaccine. The contract value is $6.3 million. The vaccine candidate ATI-1701

List Labs is proud to announce the launch of its new and improved website at www.listlabs.com.

Eon, a Denver-based healthtech leader, announced that its data science models have been expanded to now also identify incidental pulmonary nodules on Magnetic Resonance (MR) and X-Ray radiology reports